The second Session of “Strategic Discussions on Health Care,” a webinar series brought to you jointly by HR Policy Association and the Health Transformation Alliance (HTA). HRPA members, please register using the button above. HTA members, please email Alex Trujillo at [email protected] to register.
As rising health care costs and groundbreaking innovations reshape the benefits landscape, CHROs are navigating more complexity—and greater opportunity—than ever before.
Join us for a candid conversation with David Ricks, Chair and CEO of Eli Lilly and Company, one of the world’s leading pharmaceutical companies. This exclusive session is part of our Strategic Discussions on Health Care series, hosted in partnership with the Health Transformation Alliance.
In this private forum, we’ll explore:
- How employers can prepare for the impact of high-profile treatments—including GLP-1s—on employee health, expectations, and plan costs
- What HR leaders need to know about the pharma pipeline and how innovation may shift benefit design and employee experience
- How CHROs can engage strategically with industry leaders to influence the future of affordable, high-value health care
Bring your questions!
This is your opportunity to hear directly from the CEO of a company shaping the future of medicine—and to consider how those shifts affect your workforce and bottom line.
David A. Ricks
Chair and Chief Executive Officer, Eli Lilly and Company
Robert E. Andrews
CEO, Health Transformation Alliance
Richard R. Floersch
Senior Strategic Advisor, HR Policy Association and Center On Executive Compensation